ProPhase Labs, Inc.
PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio—
52W High$6.7
52W Low$0.07
ProPhase Labs, Inc. (PRPH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRPH · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.34M | $6.77M | $44.38M | $122.65M | $79.04M |
| Cost of Revenue | $2.96M | $6.92M | $28.14M | $51.99M | $46.23M |
| Gross Profit | $1.38M | ($0.15M) | $16.24M | $70.65M | $32.81M |
| Gross Margin %(computed) | 31.85% | -2.22% | 36.59% | 57.61% | 41.51% |
| Operating Expenses | |||||
| R&D Expenses | $0.11M | $0.59M | $1.42M | $0.65M | $0.52M |
| G&A Expenses | $19.32M | $37.88M | $34.50M | $46.41M | $22.49M |
| Total Operating Expenses | $19.43M | $38.48M | $37.85M | $47.06M | $23.01M |
| Operating Income | ($18.05M) | ($38.63M) | ($21.61M) | $23.59M | $9.80M |
| Operating Margin %(computed) | -415.35% | -570.59% | -48.70% | 19.24% | 12.40% |
| Interest Income | $0.00M | $0.00M | $0.08M | $0.15M | $0.64M |
| Interest Expense | $6.93M | $3.35M | $1.27M | $0.76M | $1.15M |
| Income Before Tax | ($23.39M) | ($42.33M) | ($22.40M) | $22.91M | $5.30M |
| Income Tax Expense | ($8.64M) | $7.20M | ($6.02M) | $4.45M | ($0.97M) |
| Net Income | ($14.74M) | ($53.36M) | ($16.78M) | $18.46M | $6.27M |
| Net Margin %(computed) | -339.31% | -788.24% | -37.81% | 15.05% | 7.94% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.74 | $-26.10 | $-9.80 | $11.70 | $4.10 |
| Wtd Avg Shares | 8.49M | 1.91M | 1.72M | 1.58M | 1.52M |
| EBITDA | ($11.39M) | ($32.34M) | ($14.83M) | $28.73M | $11.39M |
| EBITDA Margin %(computed) | -262.26% | -477.64% | -33.41% | 23.43% | 14.41% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more ProPhase Labs, Inc. data
About ProPhase Labs, Inc. (PRPH) Income Statement
ProPhase Labs, Inc. (PRPH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PRPH reported revenue of $0.00B, gross profit of $0.00B (gross margin 31.85%), and net income of ($0.01B) — a net profit margin of -339.31%.
Frequently asked questions
PRPH · 4 questionsProPhase Labs, Inc. (PRPH) reported revenue of $0.00B for 2025, down 35.8% year-over-year.
PRPH revenuePRPH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09